Profound Medical Corp. - common stock – Cashflow (NASDAQ:PROF) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit -20.57 M-22.36 M-25.8 M-22.3 M-23.45 M-38.21 M -38.51 M Mittelzufluss aus Investitionstätigkeit -350 K-593 K-593 K——-242 K — Zahlungsströme aus der Finanzierungstätigkeit 87.43 M5.95 M7.03 M1.46 M54.7 M41.14 M — Freier Cashflow -20.57 M-22.36 M-25.8 M-22.3 M-23.45 M-38.21 M -38.51 M

Nachrichten

Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

Top 3 Health Care Stocks That Are Set To Fly In March - BioMarin Pharmaceutical (NASDAQ:BMRN), Inspire Medical Systems (NYSE:INSP)

Profound Medical: Aktie steigt trotz Umsatzverfehlung dank starkem Gewinn pro Aktie

Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates